TrialBioMed research international2015

Phase II, open label, randomized comparative trial of ondansetron alone versus the combination of ondansetron and aprepitant for the prevention of nausea and vomiting in patients with hematologic malignancies receiving regimens containing high-dose cytarabine.

Talha Badar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.